I recently did a stock screen to find the number of U.S. stocks trading over $200. Out of 5,910 stocks, just 19 fit the bill. Among the list of companies at the time were Berkshire Hathaway (NYSE:BRK-A), Google (Nasdaq:GOOG) and Priceline.com (Nasdaq:PCLN).

However, among some of America's elite is Atrion Corporation (Nasdaq:ATRI), a Texas-based micro cap that produces niche medical products. Atrion, along with Biglari Holdings (NYSE:BH), are the only micro-caps among the group of 19 stocks. Atrion will give any of these big companies a run for their money.

Investopedia Markets: Explore the best one-stop source for financial news, quotes and insights.

Always Makes Money

I went back as far as 1990 and on only one occasion, 1997, did Atrion generate an operating loss. Even then, it would have made $1.5 million on an operating basis if the $4.8 million impairment loss for some of its patents is excluded. This is where it gets tricky. Atrion used to be known as AlaTenn Resources Inc. and operated natural gas pipelines.

In 1994, it began acquiring medical products businesses. First, it acquired Atrion Medical Products in April 1994, then it bought Halkey-Roberts in May 1996, and finally, in January 1998, it purchased QMI Medical, the cardiovascular and intravenous fluid division of Quest Medical Inc.

At the same time, it sold all of its natural gas businesses for about $38.2 million in 1997. From 1998 onward, it's been strictly a medical products business, making money for 14 straight years. In that time, revenues have grown from $30.3 million at the end of 1997 to an estimated $119 million in 2011, or 10.3% compounded annually.

Not a huge grower, its niche position allows it to make good money. In 1997, as mentioned previously, it lost $2 million on continuing operations. In 2011, operating income will be around $38 million with earnings per share of $12.84.(To know more about income statements, read Understanding The Income Statement.)

Lots of Cash

Generating more than $20 million in free cash flow annually, Atrion currently has $19.45 in cash per share. The odds of it not being able to pay its annual dividend of $1.98 is slim to none. In the past five years, it's increased its quarterly dividend at least once per annum, averaging just under 20% for each increase.

In 2010, shareholders received the motherlode, as it paid not one, but two special dividends. In January 2010, it paid a $6 special dividend and then, in time for Christmas, it paid a second $3 special dividend. That's $9 in cash that went out the door and it barely blinked finishing 2010 with $41.7 million in cash and investments.

As of the third quarter ended Sept. 30, 2011, its level of cash and investments was up 27% from the end of 2010 to $52.7 million. Considering the two special dividends amounted to an expense of $18 million in cash, it could easily afford to do the same thing in 2012. I doubt it will, but it could.

The Business Itself

Atrion generates revenue from four product lines: Fluid Delivery, Cardiovascular, Ophthalmology and Other. The fluid delivery and cardiovascular products account for approximately two-thirds of its overall revenue.

The most consistent product line in terms of revenue growth is its fluid delivery valves, which have seen revenue increases in each of the last six fiscal years and 2011 appears be no different. It's not flashy about what it does and that's what's so attractive about it. Proponents of "Made in America" policies will like the fact its products are produced exclusively in Florida, Alabama and Texas, with no offshore production.

With the exception of Novartis (NYSE:NVS), which accounts for 14% of its sales, no other organization represents more than 10% of revenue. It's sufficiently diversified, both in terms of product and customer mix. Most importantly, Atrion's revenues outside of the U.S. and Canada represent almost a quarter of its overall business and are rising at a moderate pace. Overall, its business appears very sound.

The Bottom Line

Atrion seems to do everything well. In the third quarter, it repurchased 8,000 of its shares at an average price of $189.12 a share. As of January 18, its stock is up 27% since the buyback. Over the past decade it's up 21.1% annually compared to 3.5% for the S&P 500. Hold this stock for 20 years and you might just be looking at a future mid cap. Slow and steady wins the race. (For additional reading, check out 5 Must-Have Metrics For Value Investors.)

Use the Investopedia Stock Simulator to trade the stocks mentioned in this stock analysis, risk free!
At the time of writing, Will Ashworth did not own shares in any of the companies mentioned in this article.

Related Articles
  1. Investing

    The ABCs of Bond ETF Distributions

    How do bond exchange traded fund (ETF) distributions work? It’s a question I get a lot. First, let’s explain what we mean by distributions.
  2. Stock Analysis

    3 Stocks that Are Top Bets for Retirement

    These three stocks are resilient, fundamentally sound and also pay generous dividends.
  3. Investing News

    Are Stocks Cheap Now? Nope. And Here's Why

    Are stocks cheap right now? Be wary of those who are telling you what you want to hear. Here's why.
  4. Investing News

    4 Value Stocks Worth Your Immediate Attention

    Here are four stocks that offer good value and will likely outperform the majority of stocks throughout the broader market over the next several years.
  5. Investing News

    These 3 High-Quality Stocks Are Dividend Royalty

    Here are three resilient, dividend-paying companies that may mitigate some worry in an uncertain investing environment.
  6. Stock Analysis

    An Auto Stock Alternative to Ford and GM

    If you're not sure where Ford and General Motors are going, you might want to look at this auto investment option instead.
  7. Mutual Funds & ETFs

    The 4 Best Buy-and-Hold ETFs

    Explore detailed analyses of the top buy-and-hold exchange traded funds, and learn about their characteristics, statistics and suitability.
  8. Mutual Funds & ETFs

    What Exactly Are Arbitrage Mutual Funds?

    Learn about arbitrage funds and how this type of investment generates profits by taking advantage of price differentials between the cash and futures markets.
  9. Investing News

    Ferrari’s IPO: Ready to Roll or Poor Timing?

    Will Ferrari's shares move fast off the line only to sputter later?
  10. Stock Analysis

    5 Cheap Dividend Stocks for a Bear Market

    Here are five stocks that pay safe dividends and should be at least somewhat resilient to a bear market.
  1. How do dividends affect retained earnings?

    When a company issues a cash dividend to its shareholders, the retained earnings listed on the balance sheet are reduced ... Read Full Answer >>
  2. What is the difference between called-up share capital and paid-up share capital?

    The difference between called-up share capital and paid-up share capital is investors have already paid in full for paid-up ... Read Full Answer >>
  3. Why would a corporation issue convertible bonds?

    A convertible bond represents a hybrid security that has bond and equity features; this type of bond allows the conversion ... Read Full Answer >>
  4. What types of capital are not considered share capital?

    The money a business uses to fund operations or growth is called capital, and there are a number of capital sources available. ... Read Full Answer >>
  5. How does additional paid in capital affect retained earnings?

    Both additional paid-in capital and retained earnings are entries under the shareholders' equity section of a company's balance ... Read Full Answer >>
  6. What is the difference between issued share capital and subscribed share capital?

    The difference between subscribed share capital and issued share capital is the former relates to the amount of stock for ... Read Full Answer >>

You May Also Like

Trading Center
You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!